ICM
TLYS icon

Invenomic Capital Management’s Tilly's TLYS Stock Holding History

Invenomic Capital Management’s Portfolio TLYS Stock Details TLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-47,217
Closed -$285K – 176
2020
Q3 		$285K Sell
47,217
-29,404
-38% -$185K 0.16% 119
2020
Q2 		$434K Hold
76,621
– – 0.32% 93
2020
Q1 		$316K Buy
76,621
+10,464
+16% +$76.9K 0.26% 97
2019
Q4 		$810K Buy
+66,157
New +$700K 0.33% 86

Other funds holding TLYS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Invenomic Capital Management's TLYS Position: Q4 2020 in Review

Invenomic Capital Management sold out of Tilly's (TLYS) in Q4 2020, closing a stake of 47,217 shares — an estimated $285K sold.

Invenomic Capital Management first reported a position in TLYS in Q4 2019 and held it in 4 quarters. The position peaked at $810K in Q4 2019. 79 funds tracked by Wall St. Rank hold TLYS as of Q4 2020.

  • Invenomic Capital Management reported no remaining Tilly's position as of Q4 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 47,217 Tilly's shares in Q4 2020, an estimated $285K.
  • Invenomic Capital Management first reported a position in Tilly's in Q4 2019 and held it in 4 quarters.
  • Invenomic Capital Management's Tilly's position peaked at $810K in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Tilly's as of Q4 2020.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.